Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
R. Medhat, Rania M. El-Lababidi, Manal Abdel-Salam, Ahmad Nusair
Abstract
We present, to our knowledge, the second case report of a 46-year old female who developed varicella-zoster virus (VZV) meningitis after BNT162b2 mRNA COVID-19 vaccination. The patient is immunocompetent and has no known predisposing risk factors for developing VZV meningitis. The patient received acyclovir therapy and subsequently had a complete recovery. We describe possible mechanisms of VZV meningitis after mRNA COVID-19 vaccination.
Topics & Concepts
VaccinationVaricella zoster virusMeningitisMedicineCoronavirus disease 2019 (COVID-19)VirusVirologyViral meningitisPediatricsImmunologyInternal medicineBacterial meningitisDiseaseInfectious disease (medical specialty)Herpesvirus Infections and TreatmentsSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies